KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Current Deferred Revenue (2017 - 2020)

Historic Current Deferred Revenue for Novartis Ag (NVS) over the last 4 years, with Q4 2020 value amounting to $56.0 million.

  • Novartis Ag's Current Deferred Revenue fell 5087.72% to $56.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was $56.0 million, marking a year-over-year decrease of 5087.72%. This contributed to the annual value of $56.0 million for FY2020, which is 5087.72% down from last year.
  • As of Q4 2020, Novartis Ag's Current Deferred Revenue stood at $56.0 million, which was down 5087.72% from $114.0 million recorded in Q4 2019.
  • In the past 5 years, Novartis Ag's Current Deferred Revenue ranged from a high of $305.0 million in Q4 2017 and a low of $56.0 million during Q4 2020
  • Its 4-year average for Current Deferred Revenue is $177.8 million, with a median of $175.0 million in 2018.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first plummeted by 2262.3% in 2018, then plummeted by 5169.49% in 2019.
  • Novartis Ag's Current Deferred Revenue (Quarter) stood at $305.0 million in 2017, then decreased by 22.62% to $236.0 million in 2018, then plummeted by 51.69% to $114.0 million in 2019, then crashed by 50.88% to $56.0 million in 2020.
  • Its Current Deferred Revenue was $56.0 million in Q4 2020, compared to $114.0 million in Q4 2019 and $236.0 million in Q4 2018.